Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group

PURPOSE: Given concerns that dexrazoxane may reduce treatment efficacy, induce second cancers, and thus compromise overall survival among children, we examined long-term overall and cause-specific mortality and disease relapse rates from three randomized clinical trials. PATIENTS AND METHODS: Childr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Chow, Eric J., Asselin, Barbara L., Schwartz, Cindy L., Doody, David R., Leisenring, Wendy M., Aggarwal, Sanjeev, Baker, K. Scott, Bhatia, Smita, Constine, Louis S., Freyer, David R., Lipshultz, Steven E., Armenian, Saro H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534526/
https://ncbi.nlm.nih.gov/pubmed/26014292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.59.4473
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados